VEGFR-2-mediated increased proliferation and survival in response to oxygen and glucose deprivation in PlGF knockout astrocytes

Journal of Neurochemistry

Volumn 107, Issue 3, 2008, Pages 756-767

  Freitas Andrade, Moises ^a,b   Carmeliet, Peter ^c,d   Stanimirovic, Danica B ^a,b   Moreno, Maria ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Astrocytes; Hypoxia; Proliferation; Survival; Vascular endothelial growth factor receptor 2 flk 1

Indexed keywords

GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OXYGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PLACENTAL GROWTH FACTOR; PROTEIN KINASE B; VASCULOTROPIN; VASCULOTROPIN 165; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL PROLIFERATION; CELL SURVIVAL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GENOTYPE; HYPOXIA; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; ISCHEMIA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; ASTROCYTES; BLOTTING, WESTERN; BRAIN ISCHEMIA; CELL HYPOXIA; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLUCOSE; IMMUNOHISTOCHEMISTRY; LASERS; MICE; MICE, KNOCKOUT; MICRODISSECTION; MICROSCOPY, CONFOCAL; OXYGEN; PREGNANCY PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 53749106587     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05660.x     Document Type: Article

References (48)

1. Abbott N. J., Ronnback L. Hansson E. (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nature Rev. 7, 41 53.
2. Ahmed A., Dunk C., Ahmad S. Khaliq A. (2000) Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen - a review. Placenta 21 (Suppl. A S16 S24.
3. Autiero M., Luttun A., Tjwa M. Carmeliet P. (2003a) Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. J. Thromb. Haemost. 1, 1356 1370.
4. Autiero M., Waltenberger J., Communi D. et al. (2003b) Role of PlGF in the intra- and intermolecular crosstalk between the VEGF receptors Flt1 and Flk1. Nat. Med. 9, 936 943.
5. Bachoo R. M., Kim R. S., Ligon K. L. et al. (2004) Molecular diversity of astrocytes with implications for neurological disorders. Proc. Natl Acad. Sci. USA 101, 8384 8389.
6. Bates D. O., Cui T. G., Doughty J. M., Winkler M., Sugiono M., Shields J. D., Peat D., Gillatt D. Harper S. J. (2002) VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res. 62, 4123 4131.
7. Beck H., Acker T., Puschel A. W., Fujisawa H., Carmeliet P. Plate K. H. (2002) Cell type-specific expression of neuropilins in an MCA-occlusion model in mice suggests a potential role in post-ischemic brain remodeling. J. Neuropathol. Exp. Neurol. 61, 339 350.
8. Blazquez C., Cook N., Micklem K., Harris A. L., Gatter K. C. Pezzella F. (2006) Phosphorylated KDR can be located in the nucleus of neoplastic cells. Cell Res. 16, 93 98.
9. Burbach G. J., Dehn D., Nagel B., Del Turco D. Deller T. (2004) Laser microdissection of immunolabeled astrocytes allows quantification of astrocytic gene expression. J. Neurosci. Methods 138, 141 148.
10. Cai J., Ahmad S., Jiang W. G., Huang J., Kontos C. D., Boulton M. Ahmed A. (2003) Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells. Diabetes 52, 2959 2968.
11. Cao Y., Linden P., Shima D., Browne F. Folkman J. (1996) In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor. J. Clin. Invest. 98, 2507 2511.
12. Carmeliet P. Storkebaum E. (2002) Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disorders. Semin. Cell Dev. Biol. 13, 39 53.
13. Carmeliet P., Moons L., Luttun A. et al. (2001) Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 7, 575 583.
14. Chow J., Ogunshola O., Fan S. Y., Li Y., Ment L. R. Madri J. A. (2001) Astrocyte-derived VEGF mediates survival and tube stabilization of hypoxic brain microvascular endothelial cells in vitro. Brain Res. 130, 123 132.
15. Cramer M., Nagy I., Murphy B. J., Gassmann M., Hottiger M. O., Georgiev O. Schaffner W. (2005) NF-kappaB contributes to transcription of placenta growth factor and interacts with metal responsive transcription factor-1 in hypoxic human cells. Biol. Chemistry 386, 865 872.
16. Datta S. R., Brunet A. Greenberg M. E. (1999) Cellular survival: a play in three Akts. Genes Dev. 13, 2905 2927.
17. Feng Y., Venema V. J., Venema R. C., Tsai N. Caldwell R. B. (1999) VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells. Biochem. Biophys. Res. Commun. 256, 192 197.
18. Glass C. A., Harper S. J. Bates D. O. (2006) The anti-angiogenic VEGF isoform VEGF165b transiently increases hydraulic conductivity, probably through VEGF receptor 1 in vivo. J. Physiol. 572, 243 257.
19. Grass D., Pawlowski P. G., Hirrlinger J., Papadopoulos N., Richter D. W., Kirchhoff F. Hulsmann S. (2004) Diversity of functional astroglial properties in the respiratory network. J. Neurosci. 24, 1358 1365.
20. Gollmer J. C., Ladoux A., Gioanni J., Paquis P., Dubreuil A., Chatel M. Frelin C. (2000) Expression of vascular endothelial growth factor-B in human astrocytoma. Neuro-oncology 2, 80 86.
21. Jiang Z., Zhang Y., Chen X. Q., Lam P. Y., Yang H., Xu Q. Yu A. C. (2003) Apoptosis and activation of Erkl/2 and Akt in astrocytes postischemia. Neurochem. Res. 28, 831 837.
22. Kawamura H., Li X., Harper S. J., Bates D. O. Claesson-Welsh L. (2008) Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity. Cancer Res. 68, 4683 4692.
23. Kilic E., Kilic U., Wang Y., Bassetti C. L., Marti H. H. Hermann D. M. (2006) The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia. FASEB J. 20, 1185 1187.
24. Krum J. M. Khaibullina A. (2003) Inhibition of endogenous VEGF impedes revascularization and astroglial proliferation: roles for VEGF in brain repair. Exp. Neurol. 181, 241 257.
25. Lampugnani M. G., Orsenigo F., Gagliani M. C., Tacchetti C. Dejana E. (2006) Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments. J. Cell Biol. 174, 593 604.
26. Lukaszevicz A. C., Sampaio N., Guegan C., Benchoua A., Couriaud C., Chevalier E., Sola B., Lacombe P. Onteniente B. (2002) High sensitivity of protoplasmic cortical astroglia to focal ischemia. J. Cereb. Blood Flow Metab. 22, 289 298.
27. Mani N., Khaibullina A., Krum J. M. Rosenstein J. M. (2005) Astrocyte growth effects of vascular endothelial growth factor (VEGF) application to perinatal neocortical explants: receptor mediation and signal transduction pathways. Exp. Neurol. 192, 394 406.
28. Matthias K., Kirchhoff F., Seifert G., Huttmann K., Matyash M., Kettenmann H. Steinhauser C. (2003) Segregated expression of AMPA-type glutamate receptors and glutamate transporters defines distinct astrocyte populations in the mouse hippocampus. J. Neurosci. 23, 1750 1758.
29. Mojsilovic-Petrovic J., Nesic M., Pen A., Zhang W. Stanimirovic D. (2004) Development of rapid staining protocols for laser-capture microdissection of brain vessels from human and rat coupled to gene expression analyses. J. Neurosci. Methods 133, 39 48.
30. Nedergaard M., Ransom B. Goldman S. A. (2003) New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci. 26, 523 530.
31. Santos S. C., Miguel C., Domingues I., Calado A., Zhu Z., Wu Y. Dias S. (2007) VEGF and VEGFR-2 (KDR) internalization is required for endothelial recovery during wound healing. Exp. Cell Res. 313, 1561 1574.
32. Seifert G., Schilling K. Steinhauser C. (2006) Astrocyte dysfunction in neurological disorders: a molecular perspective. Nature Rev. 7, 194 206.
33. Shintani Y., Takashima S., Asano Y. et al. (2006) Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling. EMBO J. 25, 3045 3055.
34. Shraga-Heled N., Kessler O., Prahst C., Kroll J., Augustin H. Neufeld G. (2007) Neuropilin-1 and neuropilin-2 enhance VEGF121 stimulated signal transduction by the VEGFR-2 receptor. FASEB J. 21, 915 926.
35. Shweiki D., Itin A., Soffer D. Keshet E. (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843 845.
36. Silverman W. F., Krum J. M., Mani N. Rosenstein J. M. (1999) Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures. Neuroscience 90, 1529 1541.
37. Suarez S. C., Pieren M., Cariolato L., Arn S., Hoffmann U., Bogucki A., Manlius C., Wood J. Ballmer-Hofer K. (2006) A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2. Cell. Mol. Life Sci. 63, 2067 2077.
38. Svensson B., Peters M., Konig H. G., Poppe M., Levkau B., Rothermundt M., Arolt V., Kogel D. Prehn J. H. (2002) Vascular endothelial growth factor protects cultured rat hippocampal neurons against hypoxic injury via an antiexcitotoxic, caspase-independent mechanism. J. Cereb. Blood Flow Metab. 22, 1170 1175.
39. Takahashi T., Ueno H. Shibuya M. (1999) VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells. Oncogene 18, 2221 2230.
40. Takano T., Tian G. F., Peng W., Lou N., Libionka W., Han X. Nedergaard M. (2006) Astrocyte-mediated control of cerebral blood flow. Nat. Neurosci. 9, 260 267.
41. Volterra A. Meldolesi J. (2005) Astrocytes, from brain glue to communication elements: the revolution continues. Nature Rev. 6, 626 640.
42. Wallraff A., Odermatt B., Willecke K. Steinhauser C. (2004) Distinct types of astroglial cells in the hippocampus differ in gap junction coupling. Glia 48, 36 43.
43. Woolard J., Wang W. Y., Bevan H. S. et al. (2004) VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res. 64, 7822 7835.
44. Xu L., Sapolsky R. M. Giffard R. G. (2001) Differential sensitivity of murine astrocytes and neurons from different brain regions to injury. Exp. Neurol. 169, 416 424.
45. Zachary I. (2005) Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential. Neuro-Signals 14, 207 221.
46. Zhao G. Flavin M. P. (2000) Differential sensitivity of rat hippocampal and cortical astrocytes to oxygen-glucose deprivation injury. Neurosci. Lett. 285, 177 180.
47. Zhou M. Kimelberg H. K. (2001) Freshly isolated hippocampal CA1 astrocytes comprise two populations differing in glutamate transporter and AMPA receptor expression. J. Neurosci. 21, 7901 7908.
48. Zonta M., Angulo M. C., Gobbo S., Rosengarten B., Hossmann K. A., Pozzan T. Carmignoto G. (2003) Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat. Neurosci. 6, 43 50.